[SCHEDULE 14A Check the appropriate box: [X] Preliminary Proxy Statement [ ] Definitive Proxy Statement [ ] Definitiveditional Materials JF China Region Fund, _______________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required [ ] Feemputed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11]
[SCHEDULE 13D/A (Amendment No. 11) China Yuchai International Limited (Name of Issuer)mmon Stock, Par Value $0.10 Per Share (Title of Class of Securities) G210821050 (CUSIP Number) Jinshu Zhang Reed Smith 355 South Grand Avenue, Suite 2900 Los Angeles,lifornia 90071 (213) 457-8116 (Name,dress and Telephone Number of Person]
[SCHEDULE 13D/A (Amendment No. 11) China Yuchai International Limited (Name of Issuer)mmon Stock, Par Value $0.10 Per Share (Title of Class of Securities) G210821050 (CUSIP Number) Jinshu Zhang Reed Smith 355 South Grand Avenue, Suite 2900 Los Angeles,lifornia 90071 (213) 457-8116 (Name,dress and Telephone Number of Person]
[1 Announcement in relation to Closure of Register of Members and Withholding and Payment of Enterprise Income Tax for Non-resident Enterprises in respect of 2011 Final Dividend. 2 Announcement in relation to Adjustment to Convertible Bond Conversion Price.]
[1 Announcement in relation to Closure of Register of Members and Withholding and Payment of Enterprise Income Tax for Non-resident Enterprises in respect of 2011 Final Dividend. 2 Announcement in relation to Adjustment to Convertible Bond Conversion Price.]
[CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties] [INDEMNIFICATION AGREEMENT Company Indemnitee This Indemnification Agreement, dated as of March 19, 2012, is made by and between China Biologic Products, Inc., a Delaware corporation (the RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 23, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China (+86) 10-6598-3111 (Former name or former]
[JA Solar Announces Fourth Quarter and Fiscal Year 2011 Results · Fourth Quarter Shipments of 398MW and Full Year Shipments of 1.69GW · Cash & Cash Equivalents of $617.9 Million SHANGHAI, China, March 20, 2012 (GLOBE NEWSWIRE) JA Solar Holdings Co., Ltd., (Nasdaq:JASO), (JA Solar or the Company), one of the worlds largest manufacturers of high-performance solar cells and]
[JA Solar Announces Fourth Quarter and Fiscal Year 2011 Results · Fourth Quarter Shipments of 398MW and Full Year Shipments of 1.69GW · Cash & Cash Equivalents of $617.9 Million SHANGHAI, China, March 20, 2012 (GLOBE NEWSWIRE) JA Solar Holdings Co., Ltd., (Nasdaq:JASO), (JA Solar or the Company), one of the worlds largest manufacturers of high-performance solar cells and]
